Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | AGXT | P21549 | 2/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL4224240 | 0.97 | IDO1 (0.56) | IDO1CA12CA1CA2CA7 | |
| Hydrochloric Acid SCHEMBL5608519 | 0.97 | IDO1 (0.56) | IDO1CA12CA1CA2CA7 | |
| SCHEMBL16760161 | 0.80 | TAAR1 (0.61) | IDO1CA12CA1CA2CA7 | |
| SCHEMBL1425001 | 0.78 | LTA4H (0.81) | IDO1CA12CA1CA2CA7 | |
| SCHEMBL834551 | 0.78 | TAAR1 (0.73) | IDO1CA12CA1CA2CA7 | |
| SCHEMBL27884 | 0.78 | LTA4H (0.81) | IDO1CA12CA1CA2CA7 | |
| SCHEMBL5946305 | 0.76 | ESR1 (0.32) | IDO1ALDH1A1CYP3A4TSHR | |
| 1,4-Dimethoxybenzene SCHEMBL21802643 | 0.76 | CA1 (1.00) | IDO1CA12CA1CA2CA7 | |
| 1,4-Dimethoxybenzene SCHEMBL8489 | 0.76 | CA1 (1.00) | IDO1CA12CA1CA2CA7 | |
| SCHEMBL5187124 | 0.76 | CA12 (0.61) | IDO1CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3710145-A1 | POLYCARBONATE COMPOSITIONS | BASF SE (DE) | 2020-09-23 | — | — | EP | claimed |
| CN-109096150-A | A kind of nonmetal catalyzed method for preparing beta-amino ketones of photoinduction | 中国科学技术大学 | 2018-12-28 | — | — | CN | claimed |
| CN-108299249-A | It is a kind of（S）Isopropyl methoxalamine（Jin Douer）The preparation method of key intermediate | 中国科学院成都有机化学有限公司 | 2018-07-20 | — | — | CN | claimed |
| CN-108299221-A | A kind of synthesis（S）Isopropyl methoxalamine（Jin Douer）And the like new method | 中国科学院成都有机化学有限公司 | 2018-07-20 | — | — | CN | claimed |
| CN-107043404-A | Novel phosphine gold complex and its antitumor application thereof | 中山大学肿瘤防治中心 | 2017-08-15 | — | — | CN | claimed |
| US-7030281-B2 | Synthesis of 3,3,-dimethylbutyraldehyde by the reduction of 3,3,-dimethylbutyric acid | THE NUTRASWEET COMPANY (US) | 2006-04-18 | — | — | US | claimed |
| US-20040210094-A1 | Synthesis of 3,3,-dimethylbutyraldehyde by the reduction of 3,3,-dimethylbutyric acid | THE NUTRASWEET COMPANY | 2004-10-21 | — | — | US | claimed |
| CN-1264386-A | Alkene borates and process for covalently coupling organic compounds | COMMW SCIENT IND RES ORG (AU) | 2000-08-23 | — | — | CN | claimed |
| CN-1255123-A | Method for Covalently Coupling Organic Compounds Using Diboron Derivatives | COMMW SCIENT IND RES ORG (AU) | 2000-05-31 | — | — | CN | claimed |
| EP-3710145-A1 | POLYCARBONATE COMPOSITIONS | BASF SE (DE) | 2020-09-23 | — | — | EP | disclosed |
| CN-110498757-A | A kind of synthetic method for the 3- acyl indol class compound that no metal participates in | LANZHOU INST CHEMICAL PHYSICS CAS | 2019-11-26 | — | — | CN | disclosed |
| CN-106832963-B | A kind of phosphorous network structure fire retardant | 中国科学院宁波材料技术与工程研究所 | 2019-11-26 | — | — | CN | disclosed |
| CN-110437068-A | A kind of preparation method of aromatic hydrocarbons methylation | UNIV WUHAN | 2019-11-12 | — | — | CN | disclosed |
| CN-109096150-A | A kind of nonmetal catalyzed method for preparing beta-amino ketones of photoinduction | 中国科学技术大学 | 2018-12-28 | — | — | CN | disclosed |
| CN-1646548-A | Rhodium complexes and iridium complexes | COVION ORGANIC SEMICONDUCTORS (DE) | 2005-07-27 | — | — | CN | disclosed |
| EP-1534722-A2 | RHODIUM AND IRIDIUM COMPLEXES | Covion Organic Semiconductors GmbH (DE) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004026886-A2 | RHODIUM AND IRIDIUM COMPLEXES | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2004-04-01 | — | — | WO | disclosed |
| CN-1462298-A | Radiation-sensitive composition changing in refractive index and utilization thereof | JSR CORP (JP) | 2003-12-17 | — | — | CN | disclosed |
| CN-1078496-C | Galvano-chemistry prepn. method of catalyst on basis of transition metal and phosphine | RHONE POULENC FIBRES (FR) | 2002-01-30 | — | — | CN | disclosed |
| WO-1993001810-A1 | ANALOGS OF CALICHEAMICIN η1I, METHOD OF MAKING AND USING THE SAME | THE SCRIPPS RESEARCH INSTITUTE (US) | 1993-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040210094-A1 | Synthesis of 3,3,-dimethylbutyraldehyde by the reduction of 3,3,-dimethylbutyric acid | TBCB, ABAT, HADHB | IDO1 2636/4885CA12 1300/4885CA1 607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.